“Global Radiotherapy Market is expected to grow at 7.1% in the forecast period 2016 to 2022”
Global Radiotherapy Market, By Therapy (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic), Brachytherapy (LDR, HDR), Systemic Radiotherapy), By Product Type (Cyberknife, Gammaknife, Linac, Proton Beam, Systemic Radiotherapy, Seeds, Afterloaders), By Indication (Prostate & Breast Cancer)), By Geography (North America, Europe, Asia Pacific, South America, Rest of the World) – Trends and Forecast to 2022
Global Radiotherapy Market is expected to reach USD 8.1 billion by 2022, from USD 4.9 billion in 2015 growing at a CAGR of 7.1% during the forecast period of 2016 to 2022.
Global Radiotherapy Market is segmented based on product types, therapy, application and geography.
For Sample Report: Global Radiotherapy Market – Trends and Forecast to 2022
Based on product type the market is segmented into EBRT equipment’s, and IBRT equipment’s. The External Beam Radiotherapy (EBRT) products are further segmented into cyberknife, gammaknife, LINAC, Proton Beam (Cyclotron, Synclotron). The Internal Beam Radiotherapy (IBRT) is segmented into seeds, afterloaders and others.
Based on therapy the market is segmented into external beam radiotherapy, internal beam radiotherapy, and systemic radiation therapy. On the basis of radiations delivered, the external beam radiotherapy is sub segmented into intensity-modulated radiation therapy (IMRT), image guided radiotherapy (IGRT), tomotherapy, stereotactic technology, 3D conformal radiotherapy, proton beam therapy, and volumetric modulated arc therapy (VMAT). The IGRT segment is expected to account for the largest share of the external beam radiotherapy market, whereas the VMAT segment is poised to witness the highest growth. Based on the delivery of dose-rate, the internal beam therapy is divided into low (LDR) and high-dose rate (HDR).
To read more about the scope and findings of this report visit: Global Radiotherapy Market, is expected to reach USD 8.1 billion by 2022
On the basis of indication the global radiotherapy market is segmented into brain tumor, spine cancer, lung cancer, liver cancer, breast cancer, prostate cancer and others.
Based on geography, the market report covers data for 5 regions, North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market shares countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa.
Global players operating in this market are Varian Medical Systems, Inc., CIVCO Medical Solutions, Elekta AB, Nanobiotix, Accuray Incorporated, Brainlab AG, Ion Beam Applications SA, C. R. Bard, Inc., IsoRay Medical, Inc., TRF, Nordion, Inc., RaySearch Laboratories AB, PRECISIS AG, Mevion Medical Systems, Inc., and Mitsubishi Electric Corporation among other companies.
To Browse Full Report and Pricing: Global Radiotherapy Market – Trends and Forecast to 2022
Table of Content:
1 INTRODUCTION
1.1. OVERVIEW OF THE RADIOTHERAPY MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
2 RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE RADIOTHERAPY MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.2.7. PEST ANALYSIS
2.2.8. EPIDEMIOLOGY FORECASTING MODELS
2.3. GLOBAL RADIOTHERAPY MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3 MARKET LANDSCAPE SUMMARY
4 PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. RADIOTHERAPY MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.2. RESTRAINTS
4.3.3. OPPURTUNITIES
4.3.4. THREATS
4.4. KEY MARKET FINDINGS
4.5. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5 RADIOTHERAPY MARKET, BY THERAPY TYPE
5.1. OVERVIEW
5.2. BEAM RADIOTHERAPY
5.2.1. IMAGE-GUIDED RADIOTHERAPY (IGRT)
5.2.2. INTENSITY MODULATED RADIOTHERAPY (IMRT)
5.3.3. VOLUMETRIC MODULATED ARC THERAPY (VMAT)
5.3.4. TOMOTHERAPY
5.3.5. STEREOTACTIC TECHNOLOGY
5.3.6. 3D CONFORMAL RADIOTHERAPY
5.3. BRACHYTHERAPY
5.2.1. LOW DOSE RATE (LDR)
5.2.2. HIGH DOSE RATE (HDR)
5.4. SYSTEMIC RADIOTHERAPY
6 RADIOTHERAPY MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. EXTERNAL BEAM RADIOTHERAPY EQUIPMENT
6.2.1. CYBERKNIFE
6.2.2. GAMMAKNIFE
6.2.3. LINAC
6.2.4. PROTON BEAM
6.2.4.1. CYCLOTRON
6.2.4.2. SYNCLOTRON
6.3. INTERNAL RADIOTHERAPY PRODUCTS
6.3.1. SEEDS
6.3.2. AFTERLOADERS
6.3.3. OTHERS
6.4. RADIOTHERAPY SOFTWARES
6.4.1. TREATMENT PLANNING SOFTWARES
6.4.2. DOSAGE PLANNING SOFTWARES
6.4.3. PATEINT POSITIONING SOFTWARES
6.4.4. IMAGE GUIDING SOFTWARES
6.5. SYSTEMIC RADIOTHERAPY
7 RADIOTHERAPY MARKET, BY INDICATION
7.1. OVERVIEW
7.2. BRAIN TUMOR
7.3. SPINE CANCER
7.4. LUNG CANCER
7.5. LIVER CANCER
7.6. BREAST TUMOR
7.7. PROSTRATE CANCER
7.8. OTHERS
8 PATIENT VOLUME, BY INDICATION
8.1. OVERVIEW
8.2. BRAIN TUMOR
8.3. SPINE CANCER
8.4. LUNG CANCER
8.5. LIVER CANCER
8.6. BREAST TUMOR
8.7. PROSTRATE CANCER
9 RADIOTHERAPY MARKET, BY END USER
9.1. OVERVIEW
9.2. HOSPITALS
9.3. CANCER INSTITUTES
9.4. ONCOLOGY CLINICS
10 RADIOTHERAPY MARKET, BY GEOGRAPHY
10.1. COUNTRYWISE RADIOTHERAPY MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
10.1.1. NORTH AMERICA
10.1.1.1. U.S.
10.1.1.2. CANADA
10.1.1.3. MEXICO
10.1.2. EUROPE
10.1.2.1. GERMANY
10.1.2.2. FRANCE
10.1.2.3. U.K.
10.1.2.4. ITALY
10.1.2.5. SPAIN
10.1.2.6. RUSSIA
10.1.2.7. TURKEY
10.1.2.8. BELGIUM
10.1.2.9. NETHERLANDS
10.1.2.10. SWITZERLAND
10.1.2.11. REST OF EUROPE
10.1.3. ASIA-PACIFIC (APAC)
10.1.3.1. JAPAN
10.1.3.2. CHINA
10.1.3.3. SOUTH KOREA
10.1.3.4. INDIA
10.1.3.5. AUSTRALIA
10.1.3.6. SINGAPORE
10.1.3.7. THAILAND
10.1.3.8. MALAYSIA
10.1.3.9. REST OF APAC
10.1.4. LATIN AMERICA
10.1.4.1. BRAZIL
10.1.4.2. REST OF LATIN AMERICA
10.1.5. MIDDLE EAST AND AFRICA
10.1.5.1. SOUTH AFRICA
10.1.5.2. REST OF MIDDLE EAST AND AFRICA
10.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
11 RADIOTHERAPY MARKET: COMPETITIVE LANDSCAPE
11.1. GLOBAL RADIOTHERAPY MARKET: COMPANY SHARE ANALYSIS
11.2. NORTH AMERICA RADIOTHERAPY MARKET: COMPANY SHARE ANALYSIS
11.3. EUROPE RADIOTHERAPY MARKET: COMPANY SHARE ANALYSIS
11.4. APAC RADIOTHERAPY MARKET: COMPANY SHARE ANALYSIS
11.5. MERGERS & ACQUISITIONS
11.6. NEW PRODUCT DEVELOPMENT & APPROVALS
11.7. EXPANSIONS
11.8. REGULATORY CHANGES
11.9. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
12 RADIOTHERAPY MARKET, COMPANY PROFILES
12.1 VARIAN MEDICAL SYSTEMS, INC.
12.1.1 OVERVIEW
12.1.2 SWOT ANALYSIS
12.1.3 PRODUCT PORTFOLIO
12.1.4 REVENUE ANALYSIS
12.1.5 ANALYSTS VIEW
12.2 CIVCO MEDICAL SOLUTIONS
12.2.1 OVERVIEW
12.2.2 SWOT ANALYSIS
12.2.3 PRODUCT PORTFOLIO
12.2.4 REVENUE ANALYSIS
12.2.5 ANALYSTS VIEW
12.3 ELEKTA AB
12.3.1 OVERVIEW
12.3.2 SWOT ANALYSIS
12.3.3 PRODUCT PORTFOLIO
12.3.4 REVENUE ANALYSIS
12.3.5 ANALYST VIEW
12.4 NANOBIOTIX
12.4.1 OVERVIEW
12.4.2 SWOT ANALYSIS
12.4.3 PRODUCT PORTFOLIO
12.4.4 REVENUE ANALYSIS
12.4.5 ANALYSTS VIEW
12.5 ACCURAY INCORPORATED
12.5.1 OVERVIEW
12.5.2 SWOT ANALYSIS
12.5.3 PRODUCT PORTFOLIO
12.5.4 REVENUE ANALYSIS
12.5.5 ANALYSTS VIEW
12.6 BRAINLAB AG
12.6.1 OVERVIEW
12.6.2 SWOT ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 REVENUE ANALYSIS
12.6.5 ANALYSTS VIEW
12.7 ION BEAM APPLICATIONS SA
12.7.1 OVERVIEW
12.7.2 SWOT ANALYSIS
12.7.3 PRODUCT PORTFOLIO
12.7.4 REVENUE ANALYSIS
12.7.5 ANALYSTS VIEW
12.8 C. R. BARD, INC.
12.8.1 OVERVIEW
12.8.2 SWOT ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 REVENUE ANALYSIS
12.8.5 ANALYSTS VIEW
12.9 ISORAY MEDICAL, INC.
12.9.1 OVERVIEW
12.9.2 SWOT ANALYSIS
12.9.3 PRODUCT PORTFOLIO
12.9.4 REVENUE ANALYSIS
12.9.5 ANALYSTS VIEW
12.10 TRF
12.10.1 OVERVIEW
12.10.2 SWOT ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 REVENUE ANALYSIS
12.10.5 ANALYSTS VIEW
12.11 NORDION, INC.
12.11.1 OVERVIEW
12.11.2 SWOT ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 REVENUE ANALYSIS
12.11.5 ANALYSTS VIEW
12.12 RAYSEARCH LABORATORIES AB
12.12.1 OVERVIEW
12.12.2 SWOT ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 REVENUE ANALYSIS
12.12.5 ANALYSTS VIEW
12.13 PRECISIS AG
12.13.1 OVERVIEW
12.13.2 SWOT ANALYSIS
12.13.3 PRODUCT PORTFOLIO
12.13.4 REVENUE ANALYSIS
12.13.5 ANALYSTS VIEW
12.14 MEVION MEDICAL SYSTEMS, INC.
12.14.1 OVERVIEW
12.14.2 SWOT ANALYSIS
12.14.3 PRODUCT PORTFOLIO
12.14.4 REVENUE ANALYSIS
12.14.5 ANALYSTS VIEW
12.12 MITSUBISHI ELECTRIC CORPORATION
12.12.1 OVERVIEW
12.12.2 SWOT ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 REVENUE ANALYSIS
12.12.5 ANALYSTS VIEW
13 APPENDIX
13.1 RELATED REPORTS
13.2 CUSTOMIZABLE OPTIONS
13.3 SOURCE SHEET
13.4 BIBLIOGRAPHY
14 ABOUT DATA BRIDGE MARKET RESEARCH
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are one of the largest market research firms in terms of number of reports produced, also we are proud to be the makers of the lengthiest reports in the industry owing to our in depth segmentation and large geographical coverage. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Related Reports:
Global Cord Stem Cell Banking Market – Trends and Forecast to 2022
By Storage Type (Private Banking, Public Banking), By Product Type (Cord Blood, Cord Blood & Cord Tissue), By Service Type (Collection & Transportation, Processing, Analysis, Storage), By Source (Umbilical Cord Blood, Bone Marrow, Peripheral Blood Stem, Menstrual Blood), By Indication (Cerebral Palsy, Thalassemia, Leukemia, Diabetes, Autism), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Trends and Forecast to 2022
Global Drug Delivery Devices Market – Trends and Forecast to 2022
By Product Type (Oral (Solid, Liquid,Semi-Solid), Injectable (Devices (Conventional, Self-Injectable), Formulations), Topical (Transdermal Devices (Patches, Gels), Formulations), Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Clinics, Home Healthcare, Community Healthcare, Others), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Direct Tenders, Online Pharmacy), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa, Rest of the World) – Trends and Forecast to 2022
Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Shubham Dwivedi
Email: Send Email
Phone: +1-888-387-2818
Address:Mega Center, Magarpatta City
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/global-radiotherapy-market/